NIPT (Non-Invasive Prenatal Testing)

from the 11. week of pregnancy
Objective:
  • Risk-free screening for chromosomal abnormalities at the earliest possible time in pregnancy
Nicht Invasiver Pränatal-Test (NIPT)

The Non-Invasive Prenatal Test (NIPT) involves an examination of the mother’s blood. It is suitable as a risk-free alternative to placenta puncture as well as amniocentesis. In this test, the cell-free, fragmented DNA of the child, which enters the maternal bloodstream in small quantities, is analyzed in the mother’s venous blood. The results provide information on whether Down syndrome (trisomy 21) is present with a reliability of more than 99 percent. The detection rate is 92 percent for trisomy 13 and 96 percent for trisomy 18. The test is performed in combination with an ultrasound examination. If the NIPT is performed early (11th week of pregnancy), the first quarter ultrasound including preeclampsia screening is recommended in the 12th – 14th week of pregnancy.

  • The results are available approx. 5-10 working days after the examination.

We look forward to hearing from you!